Global Norepinephrine Injection Market Research Report 2024

Publication ID:

PB507248051

Publication Date:

July 22, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Norepinephrine (NE), also called noradrenaline (NA) or noradrenalin, is an organic chemical in the catecholamine family that functions in the brain and body as a hormone and neurotransmitter.
Norepinephrine also called noradrenaline is both a hormone, produced by the adrenal glands, and a neurotransmitter, a chemical messenger which transmits signals across nerve endings in the body. Norepinephrine is produced in the inner part of the adrenal glands, also called the adrenal medulla. The adrenal medulla also makes adrenaline (also known as epinephrine). Norepinephrine, adrenaline and dopamine belong are part of the catecholamine family. Adrenal glands are making primarily adrenaline and most of the norepinephrine in the blood comes from nerve endings. It plays a role in your mood and ability to concentrate.
The global Norepinephrine Injection market was valued at US$ 440 million in 2023 and is anticipated to reach US$ 878.7 million by 2030, witnessing a CAGR of 10.0% during the forecast period 2024-2030.
North American market for Norepinephrine Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Norepinephrine Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Norepinephrine Injection include Pfizer, Novartis, Teva, Amneal Biosciences, Baxter, Mylan, Hikma Pharmaceuticals, Shanghai Harvest and Grand Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Norepinephrine Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Norepinephrine Injection.
Report Scope
The Norepinephrine Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Norepinephrine Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Norepinephrine Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Novartis
Teva
Amneal Biosciences
Baxter
Mylan
Hikma Pharmaceuticals
Shanghai Harvest
Grand Pharmaceutical
King York
Segment by Type
2mg
4mg
Other
Segment by Application
Shock Hypotensive
AMI Hypotension
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Norepinephrine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Norepinephrine Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Norepinephrine Injection Market Overview
1.1 Product Overview and Scope of Norepinephrine Injection
1.2 Norepinephrine Injection Segment by Type
1.2.1 Global Norepinephrine Injection Market Value Comparison by Type (2024-2030)
1.2.2 2mg
1.2.3 4mg
1.2.4 Other
1.3 Norepinephrine Injection Segment by Application
1.3.1 Global Norepinephrine Injection Market Value by Application: (2024-2030)
1.3.2 Shock Hypotensive
1.3.3 AMI Hypotension
1.3.4 Other
1.4 Global Norepinephrine Injection Market Size Estimates and Forecasts
1.4.1 Global Norepinephrine Injection Revenue 2019-2030
1.4.2 Global Norepinephrine Injection Sales 2019-2030
1.4.3 Global Norepinephrine Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Norepinephrine Injection Market Competition by Manufacturers
2.1 Global Norepinephrine Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Norepinephrine Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Norepinephrine Injection Average Price by Manufacturers (2019-2024)
2.4 Global Norepinephrine Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Norepinephrine Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Norepinephrine Injection, Product Type & Application
2.7 Norepinephrine Injection Market Competitive Situation and Trends
2.7.1 Norepinephrine Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Norepinephrine Injection Players Market Share by Revenue
2.7.3 Global Norepinephrine Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Norepinephrine Injection Retrospective Market Scenario by Region
3.1 Global Norepinephrine Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Norepinephrine Injection Global Norepinephrine Injection Sales by Region: 2019-2030
3.2.1 Global Norepinephrine Injection Sales by Region: 2019-2024
3.2.2 Global Norepinephrine Injection Sales by Region: 2025-2030
3.3 Global Norepinephrine Injection Global Norepinephrine Injection Revenue by Region: 2019-2030
3.3.1 Global Norepinephrine Injection Revenue by Region: 2019-2024
3.3.2 Global Norepinephrine Injection Revenue by Region: 2025-2030
3.4 North America Norepinephrine Injection Market Facts & Figures by Country
3.4.1 North America Norepinephrine Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Norepinephrine Injection Sales by Country (2019-2030)
3.4.3 North America Norepinephrine Injection Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Norepinephrine Injection Market Facts & Figures by Country
3.5.1 Europe Norepinephrine Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Norepinephrine Injection Sales by Country (2019-2030)
3.5.3 Europe Norepinephrine Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Norepinephrine Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Norepinephrine Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Norepinephrine Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Norepinephrine Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Norepinephrine Injection Market Facts & Figures by Country
3.7.1 Latin America Norepinephrine Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Norepinephrine Injection Sales by Country (2019-2030)
3.7.3 Latin America Norepinephrine Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Norepinephrine Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Norepinephrine Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Norepinephrine Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Norepinephrine Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Norepinephrine Injection Sales by Type (2019-2030)
4.1.1 Global Norepinephrine Injection Sales by Type (2019-2024)
4.1.2 Global Norepinephrine Injection Sales by Type (2025-2030)
4.1.3 Global Norepinephrine Injection Sales Market Share by Type (2019-2030)
4.2 Global Norepinephrine Injection Revenue by Type (2019-2030)
4.2.1 Global Norepinephrine Injection Revenue by Type (2019-2024)
4.2.2 Global Norepinephrine Injection Revenue by Type (2025-2030)
4.2.3 Global Norepinephrine Injection Revenue Market Share by Type (2019-2030)
4.3 Global Norepinephrine Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Norepinephrine Injection Sales by Application (2019-2030)
5.1.1 Global Norepinephrine Injection Sales by Application (2019-2024)
5.1.2 Global Norepinephrine Injection Sales by Application (2025-2030)
5.1.3 Global Norepinephrine Injection Sales Market Share by Application (2019-2030)
5.2 Global Norepinephrine Injection Revenue by Application (2019-2030)
5.2.1 Global Norepinephrine Injection Revenue by Application (2019-2024)
5.2.2 Global Norepinephrine Injection Revenue by Application (2025-2030)
5.2.3 Global Norepinephrine Injection Revenue Market Share by Application (2019-2030)
5.3 Global Norepinephrine Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Norepinephrine Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Norepinephrine Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Norepinephrine Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Novartis Norepinephrine Injection Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Norepinephrine Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Norepinephrine Injection Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Amneal Biosciences
6.4.1 Amneal Biosciences Corporation Information
6.4.2 Amneal Biosciences Description and Business Overview
6.4.3 Amneal Biosciences Norepinephrine Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Amneal Biosciences Norepinephrine Injection Product Portfolio
6.4.5 Amneal Biosciences Recent Developments/Updates
6.5 Baxter
6.5.1 Baxter Corporation Information
6.5.2 Baxter Description and Business Overview
6.5.3 Baxter Norepinephrine Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Baxter Norepinephrine Injection Product Portfolio
6.5.5 Baxter Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Norepinephrine Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mylan Norepinephrine Injection Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 Hikma Pharmaceuticals
6.6.1 Hikma Pharmaceuticals Corporation Information
6.6.2 Hikma Pharmaceuticals Description and Business Overview
6.6.3 Hikma Pharmaceuticals Norepinephrine Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hikma Pharmaceuticals Norepinephrine Injection Product Portfolio
6.7.5 Hikma Pharmaceuticals Recent Developments/Updates
6.8 Shanghai Harvest
6.8.1 Shanghai Harvest Corporation Information
6.8.2 Shanghai Harvest Description and Business Overview
6.8.3 Shanghai Harvest Norepinephrine Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Shanghai Harvest Norepinephrine Injection Product Portfolio
6.8.5 Shanghai Harvest Recent Developments/Updates
6.9 Grand Pharmaceutical
6.9.1 Grand Pharmaceutical Corporation Information
6.9.2 Grand Pharmaceutical Description and Business Overview
6.9.3 Grand Pharmaceutical Norepinephrine Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Grand Pharmaceutical Norepinephrine Injection Product Portfolio
6.9.5 Grand Pharmaceutical Recent Developments/Updates
6.10 King York
6.10.1 King York Corporation Information
6.10.2 King York Description and Business Overview
6.10.3 King York Norepinephrine Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 King York Norepinephrine Injection Product Portfolio
6.10.5 King York Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Norepinephrine Injection Industry Chain Analysis
7.2 Norepinephrine Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Norepinephrine Injection Production Mode & Process
7.4 Norepinephrine Injection Sales and Marketing
7.4.1 Norepinephrine Injection Sales Channels
7.4.2 Norepinephrine Injection Distributors
7.5 Norepinephrine Injection Customers
8 Norepinephrine Injection Market Dynamics
8.1 Norepinephrine Injection Industry Trends
8.2 Norepinephrine Injection Market Drivers
8.3 Norepinephrine Injection Market Challenges
8.4 Norepinephrine Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Pfizer
Novartis
Teva
Amneal Biosciences
Baxter
Mylan
Hikma Pharmaceuticals
Shanghai Harvest
Grand Pharmaceutical
King York

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂